PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. Author manuscript; available in PMC 2010 August 6.
Published in final edited form as:
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008 September; 25(9): 1128–1140.
PMCID: PMC2917199
NIHMSID: NIHMS64300

Mechanisms of Deoxynivalenol-Induced Gene Expression and Apoptosis

Abstract

Fusarium infection of agricultural staples such as wheat, barley and corn with concurrent production of deoxynivalenol (DON) and other trichothecene mycotoxins is an increasingly common problem worldwide. In addition to its emetic effects, chronic dietary exposure to DON causes impaired weight gain, anorexia, decreased nutritional efficiency and immune dysregulation in experimental animals. Trichothecenes are both immunostimulatory or immunosuppressive depending on dose, frequency and duration of exposure as well as type of immune function assay. Monocytes, macrophages, as well as T and B lymphocytes of the immune system can be cellular targets of DON and other trichothecenes. In vitro exposure to low trichothecene concentrations upregulates expression both transcriptionally and post-transcriptionally of cytokines, chemokines and inflammatory genes with concurrent immune stimulation, whereas exposure to high concentrations promotes leukocyte apoptosis with concomitant immune suppression. DON and other trichothecenes, via a mechanism known as the “ribotoxic stress response”, bind to ribosomes and rapidly activate mitogen-activated protein kinases (MAPKs). The latter are important transducers of downstream signaling events related to immune response and apoptosis. Using cloned macrophages, we have identified two critical upstream transducers of DON-induced MAPK activation. One transducer is double-stranded RNA-(dsRNA)-activated protein kinase (PKR), a widely-expressed serine/theonine protein kinase that can be activated by dsRNA, interferon and other agents. The other transducer is hematopoetic cell kinase (Hck), a non-receptor associated Src oncogene family kinase. Pharmacologic inhibitors and gene suppression studies have revealed that Hck and PKR contribute to DON-induced gene expression and apoptosis. PKR, Hck and other kinases bind to the ribosome and are activated following DON interaction. Future studies will focus on the sequence of molecular events at the ribosome level that drive selective activation of these upstream kinases.

Keywords: mycotoxin, Fusarium, trichothecene, immunotoxicity

Introduction

The trichothecene mycotoxins are a large group of structurally related sesquiterpenoid metabolites produced by Fusarium and other fungi often found in food and other organic substrates (Grove 1993; Grove 1988; Grove 2000). Trichothecenes are of low molecular weight (~200–500D), can diffuse rapidly into cells and can interact with the eukaryotic ribosome thereby blocking translation (Carter and Cannon 1977; Ueno 1984). All trichothecenes have in common a 9, 10 double bond and a 12, 13 epoxide group, but extensive variation exists relative to ring oxygenation patterns. Trichothecenes belonging to three structural groups are important from a public health perspective because of their presence in food or the environment (Fig. 1). These include: Type A which have isovaleryl, hydrogen, or hydroxyl moieties at the C-8 position (e.g. T-2 toxin), Type B which have a carbonyl group at the C-8 position (e.g., deoxynivalenol [DON]); and the Type D (or macrocyclic) which have a cyclic diester or triester ring linking C-4 to C-15 (e.g. satratoxin G).

Figure 1
Structures of common trichothecenes and comparative toxicity in vitro. IC20 was defined as the concentration at which 20% of proliferation of cloned murine macrophages was inhibited by each toxin. Modified from Moon et al. (2003).

Trichothecene contamination of wheat, barley and corn during Fusarium colonization is an increasingly common problem because of expanded use of “no-till farming” and changing climate patterns (McMullen et al. 1997). DON, known colloquially as “vomitoxin”, is the trichothecene most commonly detected, often at the mg kg−1 level (Abouzied et al. 1991; Lee et al. 1985; Rotter et al. 1996; Sugiura et al. 1990; Tanaka et al. 1990). Two acetylated forms of DON, 3-acetydeoxynivalenol and 15-acetyldeoxynivalenol co-occur with DON at much lower levels. These acetylated species have equivalent or lower toxicity than DON. Nivalenol, T-2 toxin and diacetoxyscirpenol have also been reported in grains, but to a lesser extent than DON.

Studies in laboratory and food animals reveal that trichothecenes elicit a complex spectrum of toxic effects. Upon acute exposure to high doses, animals exhibit a “radiomimetic” shock-like response that includes diarrhea, vomiting, leukocytosis and hemorrhage, with extremely high doses causing death (Ueno 1984). Chronic exposure to trichothecenes can cause anorexia, reduced weight gain, diminished nutritional efficiency, neuroendocrine changes and immune modulation (Pestka and Smolinski 2005).

Relative to human toxicity, trichothecenes in moldy grain are suspected to have caused a human illness known as “Alimentary Toxic Aleukia” (ATA) in the Orenburg district of the USSR from the 1930’s to the late 1940’s where mortality reached 60% in some years (Joffe 1978). ATA had as its symptoms vomiting, diarrhea, leukopenia, hemorrhage, shock and sometimes death. The disease was related to overwintered wheat, barley and millet. Since moldy grains obtained during ATA outbreaks were later found to contain trichothecene-producing fusaria, these mycotoxins are thought likely to be etiologic agents of this disease.

Human gastroenteritis with nausea, diarrhea and vomiting as primary symptoms were also frequently associated with Fusarium-infested foods between 1946 and 1963 in Japan and Korea (Yoshizawa et al. 1983)- findings which predated the discovery of the possible causative trichothecene mycotoxins. At least 32 outbreaks of food poisoning were linked to consumption of scabby wheat, barley or corn in China from 1961–1981 (Luo and X. 1994). Nearly 6000 persons were affected (63.9% attack rate). Illness occurred within 30 minutes and symptoms included nausea, vomiting, abdominal pain, diarrhea, headache, dizziness and fever. Similar, subsequent gastroenteritis outbreaks (1984–1991) in China associated with scabby/moldy cereals were found to contain DON and/or other trichothecenes. The largest outbreak affected 130,000 people with DON being found in 10 wheat samples ranging from 2 to 50 mg kg−1. In an analogous outbreak, several thousand individuals developed gastroenteritis following consumption of rain-damaged moldy wheat products in the Kashmir Valley of India (Bhat et al. 1989). DON at 0.34 to 8.4 mg kg−1 was detected in 11/24 samples taken from the affected area.

Given that food and feed are sometimes contaminated by DON and other trichothecenes, serious questions remain regarding risks from chronic ingestion to these toxins. Understanding the molecular mode of action of a mycotoxin can assist in predicting potential adverse human health effects and be used in risk assessment and risk management, as has been elegantly demonstrated for the aflatoxins (Groopman et al. 2005). The capacity to inhibit protein synthesis is thought to be central to trichothecenes’ effects in cells, tissues and intact animals (Ueno, 1984). However, many of their toxic effects might actually be related to a rapidly ensuing dysregulation of intracellular cell signaling and consequent alterations in downstream gene expression. The purpose of this review is to summarize studies conducted by our laboratory and others on the molecular mechanisms underlying DON’s aberrant immunologic and pathophysiologic.

Acute toxic effects

To characterize potential hazards, DON toxicity studies in animals typically focus on specific tissue targets, outcomes or mechanisms (Pestka and Smolinski 2005). Toxicity symptoms in sensitive species following acute DON poisoning include abdominal distress, increased salivation, malaise, diarrhea and emesis (Forsyth et al. 1977; Friend et al. 1982; Pestka et al. 1987b; Prelusky and Trenholm 1993; Young et al. 1983). Although DON is less toxic than other trichothecenes such as T-2 toxin, extremely high DON doses (i.e. unlikely to be encountered in food) can cause shock-like death. LD50 values for mice range from 49–70 and 46–78 mg/kg bw for ip and oral exposure, respectively (Forsell et al. 1987; Yoshizawa 1983). Lethal DON doses evokes histopathologic effects ranging from hemorrhage/necrosis of the intestinal tract, necrosis in bone marrow and lymphoid tissues, to kidney and heart lesions (Pestka et al. 1994a; Yoshizawa and Morooka 1977).

Even though it is considered to be one of the least lethal trichothecenes, DON’s emetic and anorectic potencies are equivalent to or exceed those reported for the more potent trichothecenes (Rotter et al. 1996). As little as 50 μg/kg bw ip or oral can cause vomiting in swine (Forsyth et al. 1977; Pestka et al. 1987a; Prelusky and Trenholm 1993). One study observed emesis in pigs occurring within minutes after ingesting feed containing 19.7 mg kg−1 DON (Young et al. 1983) which can be equated to be approximately 150 μg/kg bw/day of the toxin. Ingestion of DON at concentrations of 8 mg kg−1 and 11 mg kg−1 induce vomiting in dogs and cats, respectively (Hughes et al. 1999).

Taken together, extremely high acute DON (46–78 mg kg−1) doses are required to cause mortality or marked tissue injury in experimental mice, whereas acute exposure to relatively low doses (≥ 50 μg/kg bw) can cause vomiting in swine, a very sensitive species.

Chronic effects

Growth and food intake

Extended DON consumption in murine and porcine experimental models decreased weight gain, anorexia and altered nutritional efficiency (Rotter et al. 1996). Forsell et al. (Forsell et al. 1986) found that weight gain was depressed in weanling female B6C3F1 mice consuming 2 mg kg−1 DON. Other studies have shown weight gain suppression in mice at DON feed concentrations of 6.25 mg kg−1 (Arnold et al. 1986), 5 mg kg−1 (Robbana-Barnat et al. 1987) and 10 mg kg−1 (Hunder et al. 1991). In the most comprehensive DON feeding study reported to date, the effects of 0, 1, 5 and 10 mg kg−1 DON for 2 years were assessed in male and female B6C3F1 mice (Iverson et al. 1995). Significant body weight reduction was observed in mice fed 5 and 10 mg kg−1 DON. Food consumption was unaffected in females but decreased for male test animals at the two highest doses.

Early studies reported that DON at 1 to 2 mg kg−1 also caused partial feed refusal in pigs ingesting naturally contaminated feedstuffs, whereas 12 mg kg−1 caused complete refusal (Abbas et al. 1986; Forsyth et al. 1977; Rotter et al. 1994; Trenholm et al. 1984; Young et al. 1983). Pigs fed diets containing 2 and 4 mg kg−1 of DON exhibited a dose-related decrease in weight gain within the first 8 weeks (Bergsjo et al. 1992). The 4 mg kg−1 diet caused decreased feed intake, weight gain, and efficiency of feed utilization throughout the experiment. When clean and naturally contaminated corn were incorporated into basal diets formulated to contain DON at 0, 0.95, 1.78, and 2.85 mg kg−1, feed intake was significantly suppressed in pigs at all DON levels (Rotter et al. 1994). Decreased feed intake and weight gain occurs in castrated male pigs fed diets spiked with 3 mg kg−1 DON in naturally contaminated corn but not in pigs fed diet spiked with purified toxin (Prelusky et al. 1994). Differences between naturally contaminated feed ingredients versus feed spiked with purified DON might be attributed to the presence of additional toxins and fungal components in naturally contaminated grains that contribute additively or synergistically to DON toxicity.

The above and other studies suggest monogastric species such as mice and pigs are very sensitive to growth and weight gain suppression during subchronic and chronic DON exposure. These effects are accompanied by anorexia at higher DON concentrations in diet. The no observed adverse effect levels (NOAELs) for rodents were 0.1–0.15 mg/kg bw/day, whereas, for swine, NOAELs were 0.03–0.12 mg/kg bw/day (Pestka and Smolinski 2005).

Immunological effects

Leukocytes as targets

Investigations of host resistance, cell-mediated immune responses and humoral immunity indicate that trichothecenes are both immunostimulatory and immunosuppressive depending on dose frequency and duration of exposure as well as type of functional immune assay (Pestka et al. 2004). Leukocytes, which represent the functional cell repertoire of the immune system, are very sensitive to trichothecenes with macrophages, monocytes, B cells and T cells all being affected. Consistent with whole animal studies, dose-dependent decreases or increases in ex vivo B- and T-cell mitogen responses occur in lymphocyte cultures from animals exposed to T-2 toxin, DON or various macrocyclic trichothecenes (Friend et al. 1983; Hughes et al. 1988; Hughes et al. 1989; Hughes et al. 1990; Miller and Atkinson 1986; Tomar et al. 1987; Tomar et al. 1988). Similarly, in vitro trichothecene exposure impairs or enhances mitogen-induced lymphocyte proliferation (Atkinson and Miller 1984; Bondy et al. 1991; Cooray 1984; Hughes et al. 1988; Hughes et al. 1989; Hughes et al. 1990; Miller and Atkinson 1986; Miller and Atkinson 1987; Tomar et al. 1986; Tomar et al. 1987; Tomar et al. 1988). Based on concentrations required to inhibit proliferation of cloned macrophages or human peripheral blood mononuclear cells, trichothecene toxicity follows the rank order Type D>Type A> Type B (Forsell et al., 1985; Moon et al., 2003; Pestka and Forsell, 1988) (Fig. 1).

Gene upregulation

In addition to potentiation of mitogen responses, trichothecenes can upregulate or downregulate expression of immune- and inflammation-associated genes. Stimulation of mononuclear phagocytes by low doses or concentrations of trichothecenes elicit expression of inflammation-related genes in vivo and in vitro including cyclooxygenase-2 (COX-2) (Moon and Pestka 2002), proflammatory cytokines (Wong et al. 1998; Zhou et al. 1997) and numerous chemokines (Chung et al. 2003a; Islam et al. 2006; Kinser et al. 2004). Induction of these mediators might contribute to DON-induced growth and anorectic effects as has been described for endotoxin (Kanra et al. 2006; Schwartz 2002).

DON-induced IgA dysregulation in experimental mice is a pathologic outcome of immune gene upregulation that illustrates the complexity of trichothecene effects and has provided a portal for mechanistic exploration. Marked elevations in IgA production occur in mice fed diets containing DON or nivalenol that results in pathologic effects that closely mimic the common human glomerulonephritis, IgA nephropathy (IgAN) (Pestka 2003). These include elevations in serum IgA, circulating IgA immune complexes, kidney mesangial IgA deposits and hematuria (Dong and Pestka 1993; Dong et al. 1991; Greene et al. 1994b; Greene et al. 1994a; Greene et al. 1995; Pestka et al. 1989; Pestka et al. 1990c) as well as polyclonal activation of IgA secreting cells and polyreactive IgA autoantibody secretion (Pestka et al. 1990a; Pestka et al. 1990b; Rasooly et al. 1994; Rasooly and Pestka 1992; Rasooly and Pestka 1994). DON-induced polyclonal expansion of IgA-secreting cells in mice is mediated by increased cytokine production by macrophages (Yan et al. 1998) and T cells (Bondy and Pestka 1991; Pestka et al. 1990b; Warner et al. 1994). IL-6 induction is particularly important for DON-induced IgAN as evidenced by ex vivo studies (Yan et al. 1997) and in vivo feeding trials with IL-6 deficient mice (Pestka and Zhou 2000). Upregulation of COX-2 and resultant production of prostaglandin metabolites can also contribute to DON-induced IL-6 production in vitro and in vivo (Moon and Pestka 2003a).

Induction of apoptosis

In vivo administration of trichothecenes to rodents causes apoptosis in bone marrow, Peyer’s patches and, thymus, (Ihara et al. 1997; Ihara et al. 1998; Islam et al. 1998b; Islam et al. 1998a; Miura et al. 1998; Shinozuka et al. 1997a; Shinozuka et al. 1997b; Shinozuka et al. 1998). The hematotoxicity of trichothecenes of has been elegantly studied in the laboratory of Parent-Massin, who demonstrated that hematopoietic progenitors are a main target for apoptosis induction (Parent-Massin 2004). T-2 toxin causes apoptosis in human cord blood CD34+ hematopoietic progenitors with impaired clonal expansion of granulo-monocytes, erythrocytes and megakaryocytes precursors, whereas DON does not have the same effect (Le et al. 2005). Leukocytes are immune cells derived from hematopoiesis which defend the body against both infectious disease and foreign materials. High concentrations of trichothecene cans also evoke rapid onset of leukocyte apoptosis. DON directly induces apoptosis in T-cells, B-cells and IgA+ cells in vitro (Pestka et al. 1994b). Exposure to high trichothecene concentrations also induces apoptosis in macrophages (Yang et al. 2000; Zhou and Pestka 2003) which might suppress innate immune function (Pestka et al. 2004). DON induces apoptosis in RAW 264.7 murine macrophages, however, murine peritoneal macrophages might be less susceptible (Zhou and Pestka 2005). Accordingly, trichothecene-induced apoptosis of hematopoietic progenitors and leukocytes is very likely to contribute to immunosuppression with sensitivity to various trichothecenes differing among cell types.

Molecular mechanisms for trichothecene-mediated immune dysregulation

Trichothecene-mediated immune dysregulation is best viewed as a spectrum whereby low doses stimulate immune gene expression but as dose increases, leukocyte apoptosis ensues, leading to immunosuppression. In some cases, these disparate effects can overlap leading to complex sequelae. Understanding how changes in cell signaling and gene expression occur throughout this spectrum has yielded insight into the underlying molecular effects of trichothecenes. Such data facilitate structure function studies and can assist safety assessments for these toxins. The ensuing discussion will initially focus on the underlying mechanisms for low dose-elicited immune stimulation with respect to gene expression and then extend these concepts to high dose effects that include apoptosis and immune suppression.

Induction of gene transcription

Trichothecene-mediated elevations in cytokines, chemokines and other immune related proteins are preceded by upregulation of the respective mRNAs for these genes. Investigation of DON induction of COX-2 illustrates the underlying mechanisms for increased mRNA expression. The enzyme COX-2 catalyzes oxygenation of arachidonic acid to prostaglandin endoperoxides which are subsequently converted enzymatically into prostaglandins and thromboxane A2 (Smith et al. 2000). Resembling an early response gene, COX-2 is strongly induced by mitogenic and proinflammatory stimuli, and superinduced by protein synthesis inhibitors. We have observed induction of COX-2 gene expression in the macrophage and the mouse as well as enhanced the production of prostaglandin E2 (PGE2) in vitro (Moon and Pestka 2002). COX-2 promoter-reporter constructs were used to demonstrate that DON induces transcription of this gene in the macrophage. Although DON and other Type B trichothecenes cause COX-2 gene transactivation at equitoxic levels, representative Type A (diacetoxyscirpenol and acetyl T-2 toxin) and Type D (satratoxin F and roridin A) trichothecenes do not (Moon and Pestka 2003b). Consistent with COX-2 findings, DON elicits transcription of TNF-α and IL-6 in macrophages (Chung et al. 2003b; Jia et al. 2006), IL-8 in monocytes (Islam et al. 2006; Gray and Pestka, 2007, in press) and IL-2 expression in T cells (Li et al. 1997e).

The effects of DON have also been assessed on the transcription factors NF-κB, AP-1 and C/EBPβ, which have binding sites in the promoters of numerous immune- and inflammation-related genes. Incubation of macrophages with 100 and 250 ng/ml of DON results in increased AP-1 and C/EBP binding in nuclear extracts after 2 and 8 hrs and increased NF-κB binding after 8 hr (Wong et al., 2002). DON also increases NF-κB/Rel binding activity, in particular the transactivating forms, c-Rel and p65, in EL-4 and primary T cells (Ouyang et al. 1996b; Ouyang et al. 1996a) and U937 monocytes (Gray and Pestka, 2007, in press). DON increases AP-1 binding activity in a concentration- and time-dependent manner in EL-4 T cells (Li et al. 2000a; Li et al. 2000b) and primary macrophages (Jia et al. 2006). Both reporter studies and increased transcription factor binding are consistent with trichothecene-induced gene transcription.

Enhanced mRNA stability

DON is also able to stabilize COX-2 mRNA (Moon and Pestka 2002). mRNA stabilization is often explained by the presence of multiple copies of AUUUA motif in the 3′-untranslated region (3′-UTR) of a target mRNA, which targets a transcript for rapid degradation (Dixon et al. 2000). [Involvement of the COX-2 3′-UTR in DON-induced COX-2 expression was tested using a constitutive luciferase reporter gene with three different 3′-UTR sections (1/1558, 1/338 and 339/1558 from coding terminal sequence) of the COX-2 gene (Moon et al. 2003; Moon and Pestka 2003b). Reporter-expressing cells were treated with DON and increased luciferase was measured from cells containing reporter constructs with the COX-2 AU rich region. DON is thus likely to enhance COX-2 mRNA stability via AU-rich elements. Similarly, other COX-2-inducing Type B trichothecenes increased levels of reporter via the 3′-UTR; however, representative Type A and D trichothecenes had no marked effect at equitoxic concentrations. Accordingly, AU rich repeats in the 3′-UTR are likely to be involved in mRNA stabilization by COX-2-inducing Type B trichothecenes].

As found for COX-2, DON can stabilize mRNAs for TNF-α (Chung et al. 2003b; Chung et al. 2003a) and IL-6 (Jia et al. 2006) in macrophages as well as IL-2 in EL-4 T cells, (Li et al. 1997a; Li et al. 1997b; Li et al. 1997c; Li et al. 1997d; Li et al. 1997e). Contrastingly, mRNA stabilization dose not play a role in DON-induced IL-8 in monocytes (Gray and Pestka, 2007, in press).

Mitogen-activated protein kinase activation

Since the ribosome is the primary molecular target for trichothecenes, translational inhibition is an obvious mechanism of toxicity (Ueno 1984). Trichothecenes and other ribosome-binding translational inhibitors, however, can also rapidly activate mitogen-activated protein kinases (MAPKs) via a process termed the “ribotoxic stress response” (Iordanov et al. 1997; Laskin et al. 2002). These kinases modulate numerous physiological processes including cell growth, differentiation and apoptosis (Cobb 1999) and are crucial for signal transduction in the immune response (Dong et al. 2002). The primary MAPK subfamilies are (i) p44 and p42 MAPKs, also known as extracellular signal regulated protein kinase 1 and 2 (ERK1 and 2); (ii) p54 and p46 c-Jun N-terminal kinase 1 and 2 (JNK 1/2) and (iii) p38 MAPK (Cobb 1999; Schaeffer and Weber 1999; Widmann et al. 1999).

The capacity of DON and other trichothecenes to activate JNK, ERK and p38 in vitro (Moon and Pestka 2002; Shifrin and Anderson 1999; Yang et al. 2000; Zhou and Pestka 2003) and in vivo (Zhou et al. 2003a) led us to hypothesize that immune dysregulation and perhaps other toxic manifestations of these mycotoxins are regulated by the ribotoxic stress response. Indeed, ERK and p38 are involved in trichothecene-induced transactivation of TNF-α and COX-2, while p38 contributes to trichothecene-mediated mRNA stability (Chung et al. 2003b; Moon and Pestka 2002; Moon and Pestka 2003a; Moon et al. 2003). Similar findings have been made for IL-6 and IL-8 in primary human mononuclear blood cell cultures (Islam et al. 2006).

Integrated in vivo model for trichothecene-induced gene expression

Proinflammatory cytokine mRNA expression is induced within lymphoid tissue in vivo by DON in a rapid (1–2 hr) and transient (4–8 hr) fashion (Azcona-Olivera et al. 1995a; Zhou et al. 1997; Zhou et al. 1998; Zhou et al. 1999) which suggests that relevant MAPKs and transcription factors associated with cytokine expression are activated prior To test this possibility, we treated mice with a single oral dose of DON and then their spleens were analyzed for MAPK phosphorylation and transcription factor activation over time (Zhou et al. 2003a). As little as 1 mg/kg bw of DON induced JNK 1/2, ERK 1/2, and p38 phosphorylation with maximal effects being observed at 5 to 100 mg/kg bw. JNK and p38 phosphorylation were also transiently induced over a 60 min time period with peak effects being observed at 15 and 30 min, respectively, whereas ERK remained phosphorylated between 15 to 120 min. MAPK phosphorylation kinetics were consistent with the absorption and clearance of DON in the mouse, which peaks at 30 min in most tissues (Azcona-Olivera et al. 1995c; Azcona-Olivera et al. 1995a; Azcona-Olivera et al. 1995b). Regarding transcription factors assessed at 25 mg/kg bw DON, AP-1 binding activity was elevated from 0.5 h to 8 h, whereas C/EBP binding was elevated only at 0.5 h. CREB binding decreased slightly at 0.5 h but gradually increases, reaching a maximum at 4 h. NF-κB binding increased slightly at 4 h and 8 h. TNF-α, IL-1β and IL-6 mRNA were found to peak at 3 h and were still significantly elevated at 6 h but not 9 h. These in vivo data suggest that DON induces MAPK activation and then, either concurrently or subsequently, activates transcription factors specific for regulatory motifs in cytokine promoters. The kinetics of these events are highly consistent with downstream proinflammatory gene expression in the spleens of mice exposed to DON (Azcona-Olivera et al. 1995a; Zhou et al. 1997; Zhou et al. 1998; Zhou et al. 1999).

Upstream transducers of MAPKs

Since DON and other trichothecenes activate MAPKs, the next logical investigation was to identify possible upstream transducers. Using chemical inhibitors of potential upstream kinases, we identified two putative upstream kinases - double-stranded RNA-(dsRNA)-activated protein kinase (PKR) and hemoitopoeitic cell kinase (Hck).

PKR is a widely-expressed serine/theonine protein kinase that is activated by dsRNA, interferon and other agents (Williams 2001). PKR’s first identified roles were translational inhibition via phosphorylation of eukaryotic initiation factor 2α (eIF2α) - an evolutionarily conserved antiviral response. In addition to eIF2α phosphorylation and auto-phosphorylation activities, PKR has a wide serine-theonine kinase substrate specificity. PKR might also act through protein-protein interactions which do not necessitate catalytic action. PKR acts as a signal integrator for ligand-activated stress-activated protein kinase pathways leading to stimulation of JNK and p38. This kinase is also thought to mediate apoptosis induced by dsRNA, LPS and TNF-α (Der et al. 1997; Yeung et al. 1996). PKR potentially modulates induction of cytokines including TNF-α (Meusel et al. 2002), IL-6 and IL-12 (Goh et al. 2000).

In macrophages, PKR is activated within 1 to 5 min as evidenced by autophosphorylation and by phosphorylation of eIF2α, which is rapidly then degraded (Zhou et al. 2003b). Both antisense PKR expression vector and PKR inhibitors suppress induction of JNK, p38 and ERK phosphorylation by DON, emetine and anisomycin. These data indicate that PKR plays a critical upstream role in the ribotoxic stress response inducible by translational inhibitors. PKR suppression also inhibits induction of TNF-α and MIP-2 by DON (Pestka et al. 2004) as well as IL-8 (Gray and Pestka, 2007, in press). Therefore, PKR might mediate early events leading to immunotoxicity associated with leukocyte exposure to DON and other trichothecenes and, furthermore, might be an early target for the ribotoxic stress response.

Hck belongs to the highly conserved Src oncogene family of cytoplasmic protein tyrosine kinases and is specifically expressed in myelomonocytic cell lineages (Tsygankov 2003). Hck transduces extracellular signals that modulate cellular processes involving proliferation, differentiation and migration (Ernst et al. 2002). Src-family-selective tyrosine kinase inhibitors effectively suppress DON-induced activation of MAPKs, which suggests Hck involvement (Zhou et al. 2005b). As expected for a signaling event upstream of MAPK activation, tyrosine phosphorylation of Hck is detectable as early as 1 min, maximized at 2.5 min then declines within 30 min after DON addition. Specific pharmacologic inhibition of Hck ablates DON-induced phosphorylation of c-jun, ATF-2 and p90Rsk, which are substrates of JNK, p38 or ERK, respectively (Pestka and Zhou 2003). Hck inhibition also suppresses DON-induced increases in nuclear levels and binding activities of several transcription factors (NF-κB, AP-1 and C/EBP), which correspond to decreased TNF-α production, caspase-3 activation and apoptosis. Knockdown of Hck expression with small interfering RNAs confirmed involvement of this Src in DON-induced TNF-α production and caspase activation. Taken together, activation of Hck and possibly other Src family tyrosine kinases is likely to be another critical signal that precedes both MAPK activation and induction of resultant downstream sequelae by DON and other ribotoxic stressors.

Ribosome-kinase interactions

Recently, we assessed the capacity of PKR, Hck and ERK to interact with ribosomes (Bae and Pestka 2006). Sequence analysis revealed that many ribosomal proteins subunits contain putative kinase docking sites. Indeed, extremely rapid association and/or activation of PKR, Hck, p38 and ERK are detectable in ribosomes of DON-treated macrophages. Earliest activation of kinases (1–3 min) was detectable in the monosome fraction with a subsequent localization to the polysome fraction (3–5 min). Other kinases such PDK1, AKT and p70 RSK1, also bound to ribosomes. These observations suggest that, following DON interaction, the ribosome might function as signal transducer and/or scaffold, thereby mediating activation and binding of several protein kinases, some of which are upstream to the MAPKs (Fig. 2). These interactions are very likely to impact transcriptional and post-transcriptional regulation of stress- and immune-related genes.

Figure 2
Mechanisms leading to DON-induced immune dysregulation. DON induces p38 and ERK MAPKs via PKR and HCK. MAPK activation drives increased proinflammatory gene expression or of proinflammatory cytokines might include anorexia, reduced weight gain, immune ...

Upstream transducers of trichothecene-induced apoptosis

Trichothecene-mediated apoptosis also correlates closely with activation of all three MAPK families in RAW 264.7 macrophage and U937 monocyte models suggesting a possible contributing role for these kinases (Yang et al. 2000). The capacity of individual trichothecenes to promote MAPK phosphorylation correlates with protein synthesis inhibition and precedes apoptosis. p38 inhibition inhibits DON- induced apoptosis, whereas ERK inhibition enhances apoptosis. Accordingly, p38 and ERK might upregulate and downregulate trichothecene-induced apoptosis, respectively.

When upstream signaling transduction mechanisms contributing to DON-mediated apoptosis were investigated in macrophages, PKR and Hck inhibition, additively inhibited DON-induced caspase-3 activity and apoptosis as well as p38, ERK and JNK phosphorylation (Zhou et al. 2003b; Zhou et al. 2005b). PKR and Hck inhibition also inhibited DON-induced p53 binding activity and subsequent phosphorylation of its substrate p21. The capacity of MAPKs to mediate both apoptosis and survival was further assessed by Zhou et al. (Zhou et al. 2005a) in DON-exposed macrophages. At concentrations which partially inhibit translation, DON induced phosphorylation of p38 and ERK 1/2 mitogen activated protein kinases within 15 min in macrophages and these effects lasted up to 3 h. DON-exposed cells exhibited marked caspase 3-dependent DNA fragmentation after 6 h which was suppressed and attenuated by the p38 inhibition and ERK inhibition, respectively. DON readily induced the phosphorylation and activity of p53 which was suppressed by p38 inhibition. DON exposure elicited BAX translocation to mitochondria and corresponding cytochrome C release but did not alter mitochondrial membrane potential. The p53 inhibitor PFT α reduced both DON-induced phosphorylation of p53 and p53 binding activity. Moreover, both PFT α and p53 siRNA transfection suppressed DON-induced caspase-3 activity and subsequent DNA fragmentation. Concurrent with p53 activation, DON activated two anti-apoptotic survival pathways as evidenced by both ERK-dependent activation of both p90 Rsk and AKT. Taken together, the results indicate that DON-induced ribotoxic stress response initiates competing apoptotic (p38→p53→Bax→Mitochondria→ Caspase-3) and survival (ERK→AKT/p90Rsk→Bad) pathways in the macrophages (Fig. 2).

Summary

Leukocytes are central targets of DON and other trichothecenes, which can be immunostimulatory and immunosuppressive depending on exposure regimen and functional immunologic endpoint. Low dose DON exposure transcriptionally and post-transcriptionally upregulates expression of cytokines, chemokines and inflammatory genes with concurrent immune stimulation. High dose DON exposure promotes leukocyte apoptosis with concomitant immune suppression. MAPKs, in particular p38, are important transducers of downstream signaling events related to trichothecene-induced immune stimulation and apoptosis. Inhibitor and gene silencing studies have revealed that Hck and PKR play upstream roles in DON-induced MAPK phosphorylation and subsequent induction of gene expression and apoptosis.. A summary of these interactions is provided in Fig. 3. It is tempting to speculate that p38 and ERK act as molecular rheostats and define response. When ERK and p38 are activated, immune gene expression and antiapoptotic pathways are favored. When only p38 is activated, an apoptotic response ensues. Future studies should focus on (1) relating the magnitude and duration of trichothecene-induced activation of MAPKs to immune and apoptotic gene expression, (2) understanding the molecular linkages of PKR, Hck and other kinases to the ribosomes and (3) uncovering the exact mechanisms of interaction among upstream kinases and MAPKs as well as downstream mediators of trichothecene-induced gene expression and apoptosis. Ultimately, paradigms derived from such basic studies must be evaluated in the context of human leukocytes as a function of toxin distribution/metabolism, genetic polymorphisms, nutrition, environmental chemical exposure, microbial infection and ongoing inflammatory responses.

Figure 3
Depiction of DON-induced ribotoxic stress response. Binding of DON causes conformational change and/or damage to ribosome thereby driving protein kinase mobilization, phosphorylation and activation. The ensuing intracellular kinase cascades direct gene ...

References

  • Abbas HK, Mirocha CJ, Tuite J. Natural occurrence of deoxynivalenol, 15-acetyl-deoxynivalenol, and zearalenone in refusal factor corn stored since 1972. Applied Environ Microbiol. 1986;51(4):841–843. [PMC free article] [PubMed]
  • Abouzied MM, Azcona JI, Braselton WE, Pestka JJ. Immunochemical assessment of mycotoxins in 1989 grain foods: evidence for deoxynivalenol (vomitoxin) contamination. Appl Environ Microbiol. 1991;57(3):672–677. [PMC free article] [PubMed]
  • Arnold DL, McGuire PF, Nera EA, Karpinski KF, Bickis MG, Zawidzka ZZ, Fernie S, Vesonder RF. The toxicity of orally administered deoxynivalenol (vomitoxin) in rats and mice. Food Chem Toxicol. 1986;24(9):935–941. [PubMed]
  • Atkinson HA, Miller K. Inhibitory effect of deoxynivalenol, 3-acetyldeoxynivalenol and zearalenone on induction of rat and human lymphocyte proliferation. Toxicol Lett. 1984;23(2):215–221. [PubMed]
  • Azcona-Olivera JI, Ouyang Y, Murtha J, Chu FS, Pestka JJ. Induction of cytokine mRNAs in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): relationship to toxin distribution and protein synthesis inhibition. Toxicol Appl Pharmacol. 1995a;133(1):109–120. [PubMed]
  • Azcona-Olivera JI, Ouyang Y, Murtha J, Chu FS, Pestka JJ. Induction of cytokine mRNAs in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): relationship to toxin distribution and protein synthesis inhibition. Toxicol Appl Pharmacol. 1995b;133(1):109–120. [PubMed]
  • Azcona-Olivera JI, Ouyang YL, Warner RL, Linz JE, Pestka JJ. Effects of vomitoxin (deoxynivalenol) and cycloheximide on IL-2, 4, 5 and 6 secretion and mRNA levels in murine CD4+ cells. Food Chem Toxicol. 1995c;33(6):433–441. [PubMed]
  • Bae HK, Pestka JJ. Protein kinases associate ribosomes during the deoxynivalenol-nduced ribotoxic stress response in the macrophage. The Toxicologist. 2006;90:206.
  • Bergsjo B, Matre T, Nafstad I. Effects of diets with graded levels of deoxynivalenol on performance in growing pigs. Zentralbl Veterinarmed [A] 1992;39(10):752–758. [PubMed]
  • Bhat RV, Beedu SR, Ramakrishna Y, Munshi KL. Outbreak of trichothecene mycotoxicosis associated with consumption of mould-damaged wheat production in Kashmir Valley, India. Lancet. 1989;1(8628):35–37. [PubMed]
  • Bondy GS, McCormick SP, Beremand MN, Pestka JJ. Murine lymphocyte proliferation impaired by substituted neosolaniols and calonectrins--Fusarium metabolites associated with trichothecene biosynthesis. Toxicon. 1991;29(9):1107–1113. [PubMed]
  • Bondy GS, Pestka JJ. Dietary exposure to the trichothecene vomitoxin (Deoxynivalenol) stimulates terminal differentiation of Peyer’s patch B cells to IgA secreting plasma cells. Toxicol Appl Pharmacol. 1991;108(3):520–530. [PubMed]
  • Carter CJ, Cannon M. Structural requirements for the inhibitory action of 12,13-epoxytrichothecenes on protein synthesis in eukaryotes. Biochem J. 1977;166(3):399–409. [PubMed]
  • Chung YJ, Yang GH, Islam Z, Pestka JJ. Toxicology. 1–2. Vol. 186. 2003a. Up-regulation of macrophage inflammatory protein-2 and complement 3A receptor by the trichothecenes deoxynivalenol and satratoxin G; pp. 51–65. [PubMed]
  • Chung YJ, Zhou HR, Pestka JJ. Transcriptional and posttranscriptional roles for p38 mitogen-activated protein kinase in upregulation of TNF-alpha expression by deoxynivalenol (vomitoxin) Toxicol Appl Pharmacol. 2003b;193(2):188–201. [PubMed]
  • Cobb MH. MAP kinase pathways. Prog Biophys Mol Biol. 1999;71(3–4):479–500. [PubMed]
  • Cooray R. Effects of some mycotoxins on mitogen-induced blastogenesis and SCE frequency in human lymphocytes. Food Chem Toxicol. 1984;22(7):529–534. [PubMed]
  • Der SD, Yang YL, Weissmann C, Williams BR. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc Natl Acad Sci U S A. 1997;94(7):3279–3283. [PubMed]
  • Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J Biol Chem. 2000;275(16):11750–11757. [PubMed]
  • Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annu Rev Immunol. 2002;20:55–72. [PubMed]
  • Dong W, Pestka JJ. Persistent dysregulation of IgA production and IgA nephropathy in the B6C3F1 mouse following withdrawal of dietary vomitoxin (deoxynivalenol) Fundam Appl Toxicol. 1993;20(1):38–47. [PubMed]
  • Dong W, Sell JE, Pestka JJ. Quantitative assessment of mesangial immunoglobulin A (IgA) accumulation, elevated circulating IgA immune complexes, and hematuria during vomitoxin-induced IgA nephropathy. Fundam Appl Toxic Off J Soc Toxicol. 1991;17(1):197–207. [PubMed]
  • Ernst M, Inglese M, Scholz GM, Harder KW, Clay FJ, Bozinovski S, Waring P, Darwiche R, Kay T, Sly P, Collins R, Turner D, Hibbs ML, Anderson GP, Dunn AR. Constitutive activation of the SRC family kinase Hck results in spontaneous pulmonary inflammation and an enhanced innate immune response. J Exp Med. 2002;196(5):589–604. [PMC free article] [PubMed]
  • Forsell JH, Jensen R, Tai JH, Witt M, Lin WS, Pestka JJ. Comparison of acute toxicities of deoxynivalenol (vomitoxin) and 15-acetyldeoxynivalenol in the B6C3F1 mouse. Food Chem Toxicol. 1987;25(2):155–162. [PubMed]
  • Forsell JH, Pestka JJ. Relation of 8-ketotrichothecene and zearalenone analog structure to inhibition of mitogen-induced human lymphocyte blastogenesis. Appl Environ Microbiol. 1985;50(5):1304–1307. [PMC free article] [PubMed]
  • Forsell JH, Witt MF, Tai JH, Jensen R, Pestka JJ. Effects of 8-week exposure of the B6C3F1 mouse to dietary deoxynivalenol (vomitoxin) and zearalenone. Food Chem Toxicol. 1986;24(3):213–219. [PubMed]
  • Forsyth DM, Yoshizawa T, Morooka N, Tuite J. Emetic and refusal activity of deoxynivalenol to swine. Appl Environ Microbiol. 1977;34(5):547–552. [PMC free article] [PubMed]
  • Friend DW, Trenholm HL, Elliot JI, Thompson BK, Hartin KE. Effect of feeding vomitoxin-contaminated wheat to pigs. Canadian Journal of Animal Science. 1982;62:1211–1222.
  • Friend SC, Babiuk LA, Schiefer HB. The effects of dietary T-2 toxin on the immunological function and herpes simplex reactivation in Swiss mice. Toxicol Appl Pharmacol. 1983;69(2):234–244. [PubMed]
  • Goh KC, deVeer MJ, Williams BR. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J. 2000;19(16):4292–4297. [PubMed]
  • Gray JS, Pestka JJ. Transcriptional regulation of deoxynivalenol-Induced IL-8 expression in human monocytes. Toxicol Sci. 2007 (in press) [PubMed]
  • Greene DM, Azcona Olivera JI, Murtha JM, Pestka JJ. Effects of dihydrotestosterone and estradiol on experimental IgA nephropathy induced by vomitoxin. Fundam Appl Toxicol. 1995;26(1):107–116. [PubMed]
  • Greene DM, Azcona Olivera JI, Pestka JJ. Vomitoxin (deoxynivalenol)-induced IgA nephropathy in the B6C3F1 mouse: dose response and male predilection. Toxicology. 1994a;92(1–3):245–260. [PubMed]
  • Greene DM, Bondy GS, Azcona Olivera JI, Pestka JJ. Role of gender and strain in vomitoxin-induced dysregulation of IgA production and IgA nephropathy in the mouse. J Toxicol Environ Health. 1994b;43(1):37–50. [PubMed]
  • Groopman JD, Johnson D, Kensler TW. Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk. Cancer Biomark. 2005;1(1):5–14. [PubMed]
  • Grove JF. Macrocyclic trichothecenes. Nat Prod Rep. 1993;10:429–448.
  • Grove JF. Non-macrocyclic trichothecenes. Nat Prod Rep. 1988;5(2):187–209. [PubMed]
  • Grove JF. Non-macrocyclic trichothecenes Part 2. Prog Chem Org Nat Prod. 2000;69:1–70.
  • Hughes BJ, Hsieh GC, Jarvis BB, Sharma RP. Effects of macrocyclic trichothecene mycotoxins on the murine immune system. Arch Environ Contam Toxicol. 1989;18(3):388–395. [PubMed]
  • Hughes BJ, Jarvis BB, Sharma RP. Effects of macrocyclic trichothecene congeners on the viability and mitogenesis of murine splenic lymphocytes. Toxicol Lett. 1990;50(1):57–67. [PubMed]
  • Hughes BJ, Taylor MJ, Sharma RP. Effects of verrucarin A and roridin A, macrocyclic trichothecene mycotoxins, on the murine immune system. Immunopharmacology. 1988;16(2):79–87. [PubMed]
  • Hughes DM, Gahl MJ, Graham CH, Grieb SL. Overt signs of toxicity to dogs and cats of dietary deoxynivalenol. J Anim Sci. 1999;77(3):693–700. [PubMed]
  • Hunder G, Schumann K, Strugala G, Gropp J, Fichtl B, Forth W. Influence of subchronic exposure to low dietary deoxynivalenol, a trichothecene mycotoxin, on intestinal absorption of nutrients in mice. Food Chem Toxicol. 1991;29(12):809–814. [PubMed]
  • Ihara T, Sugamata M, Sekijima M, Okumura H, Yoshino N, Ueno Y. Apoptotic cellular damage in mice after T-2 toxin-induced acute toxicosis. Nat Toxins. 1997;5(4):141–145. [PubMed]
  • Ihara T, Yamamoto T, Sugamata M, Okumura H, Ueno Y. The process of ultrastructural changes from nuclei to apoptotic body. Virchows Arch. 1998;433(5):443–447. [PubMed]
  • Iordanov MS, Pribnow D, Magun JL, Dinh TH, Pearson JA, Chen SL, Magun BE. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA. Mol Cell Biol. 1997;17(6):3373–3381. [PMC free article] [PubMed]
  • Islam Z, Gray JS, Pestka JJ. p38 Mitogen-activated protein kinase mediates IL-8 induction by the ribotoxin deoxynivalenol in human monocytes. Toxicol Appl Pharmacol. 2006;213(3):235–244. [PubMed]
  • Islam Z, Nagase M, Yoshizawa T, Yamauchi K, Sakato N. T-2 toxin induces thymic apoptosis in vivo in mice. Toxicol Appl Pharmacol. 1998a;148(2):205–214. [PubMed]
  • Islam Z, Nagase M, Yoshizawa T, Yamauchi K, Sakato N. T-2 toxin induces thymic apoptosis in vivo in mice. Toxicol Appl Pharmacol. 1998b;148(2):205–214. [PubMed]
  • Iverson F, Armstrong C, Nera E, Truelove J, Fernie S, Scott P, Stapley R, Hayward S, Gunner S. Chronic feeding study of deoxynivalenol in B6C3F1 male and female mice. Teratog Carcinog Mutagen. 1995;15(6):283–306. [PubMed]
  • Jia Q, Zhou HR, Shi Y, Pestka JJ. Docosahexaenoic acid consumption inhibits deoxynivalenol-induced CREB/ATF1 activation and IL-6 gene transcription in mouse macrophages. J Nutr. 2006;136(2):366–372. [PubMed]
  • Joffe AZ. Fusarium poae and F. sporotichiodes as pricipal causal agents of alimentary toxic aleukia. In: Wyllie TD, Morehouse LG, editors. Mycotoxic Fungi, Mycotoxins, Mycotoxicoses: An Encylcopedic Handbook. Dekker; New York: 1978. pp. 21–86.
  • Kanra GY, Ozen H, Kara A. Infection and anorexia. Turk J Pediatr. 2006;48(4):279–287. [PubMed]
  • Kinser S, Jia Q, Li M, Laughter A, Cornwell P, Corton JC, Pestka J. Gene expression profiling in spleens of deoxynivalenol-exposed mice: immediate early genes as primary targets. J Toxicol Environ Health A. 2004;67(18):1423–1441. [PubMed]
  • Laskin JD, Heck DE, Laskin DL. The ribotoxic stress response as a potential mechanism for MAP kinase activation in xenobiotic toxicity. Toxicol Sci. 2002;69(2):289–291. [PubMed]
  • Le DG, Auffret M, Batina P, Arnold F, Sibiril Y, Arzur D, Parent-Massin D. Myelotoxicity of trichothecenes and apoptosis: an in vitro study on human cord blood CD34+ hematopoietic progenitor. Toxicol In Vitro. 2005;19(8):1015–1024. [PubMed]
  • Lee US, Jang HS, Tanaka T, Hasegawa A, Oh YJ, Ueno Y. The coexistence of the Fusarium mycotoxins nivalenol, deoxynivalenol and zearalenone in Korean cereals harvested in 1983. Food Addit Contam. 1985;2(3):185–192. [PubMed]
  • Li G, Shinozuka J, Uetsuka K, Nakayama H, Doi K. T-2 toxin-induced apoptosis in intestinal crypt epithelial cells of mice. Exp Toxicol Pathol. 1997a;49(6):447–450. [PubMed]
  • Li J, Shimizu T, Miyoshi N, Yasuda N. Rapid apoptotic changes in the gastric glandular epithelium of rats administered intraperitoneally with fusarenon-X. J Vet Med Sci. 1997b;59(1):17–22. [PubMed]
  • Li L, Cousart S, Hu J, McCall CE. Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J Biol Chem. 2000a;275(30):23340–23345. [PubMed]
  • Li P, Allen H, Banerjee S, Seshadri T. Characterization of mice deficient in interleukin-1 beta converting enzyme. J Cell Biochem. 1997c;64(1):27–32. [PubMed]
  • Li S, Ouyang Y, Yang GH, Pestka JJ. Modulation of transcription factor AP-1 activity in murine EL-4 thymoma cells by vomitoxin (deoxynivalenol) Toxicol Appl Pharmacol. 2000b;163(1):17–25. [PubMed]
  • Li S, Ouyang YL, Dong W, Pestka JJ. Superinduction of IL-2 gene expression by vomitoxin (deoxynivalenol) involves increased mRNA stability. Toxicol Appl Pharmacol. 1997d;147(2):331–342. [PubMed]
  • Li X, Hales KH, Watanabe G, Lee RJ, Pestell RG, Hales DB. The effect of tumor necrosis factor-alpha and cAMP on induction of AP-1 activity in MA-10 tumor Leydig cells. Endocrine. 1997e;6(3):317–324. [PubMed]
  • Luo X. Food poisoning caused by Fusarium toxins. ILSI Thailand. Proceedings of the Second Asian Conference on Food Safety.1994. pp. 129–136.
  • McMullen M, Jones R, Gallenberg D. Scab of wheat and barley: a re-emerging disease of devasting impact. Plant Disease. 1997;81(12):1340–1348.
  • Meusel TR, Kehoe KE, Imani F. Protein kinase R regulates double-stranded RNA induction of TNF-alpha but not IL-1 beta mRNA in human epithelial cells. J Immunol. 2002;168(12):6429–6435. [PubMed]
  • Miller K, Atkinson HA. The in vitro effects of trichothecenes on the immune system. Food Chem Toxicol. 1986;24(6–7):545–549. [PubMed]
  • Miller K, Atkinson HA. The in vitro effects of trichothecenes on the immune system. Arch Toxicol Suppl. 1987;11:321–324. [PubMed]
  • Miura K, Nakajima Y, Yamanaka N, Terao K, Shibato T, Ishino S. Induction of apoptosis with fusarenon-X in mouse thymocytes. Toxicology. 1998;127(1–3):195–206. [PubMed]
  • Moon Y, Pestka JJ. Vomitoxin-induced cyclooxygenase-2 gene expression in macrophages mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases. Toxicol Sci. 2002;69(2):373–382. [PubMed]
  • Moon Y, Pestka JJ. Cyclooxygenase-2 mediates interleukin-6 upregulation by vomitoxin (deoxynivalenol) in vitro and in vivo. Toxicol Appl Pharmacol. 2003a;187(2):80–88. [PubMed]
  • Moon Y, Pestka JJ. Deoxynivalenol-induced mitogen-activated protein kinase phosphorylation and IL-6 expression in mice suppressed by fish oil. J Nutr Biochem. 2003b;14(12):717–726. [PubMed]
  • Moon Y, Uzarski R, Pestka JJ. Relationship of trichothecene structure to COX-2 induction in the macrophage: selective action of type B (8-keto) trichothecenes. J Toxicol Environ Health A. 2003;66(20):1967–1983. [PubMed]
  • Ouyang YL, Azcona Olivera JI, Murtha J, Pestka JJ. Vomitoxin-mediated IL-2, IL-4, and IL-5 superinduction in murine CD4+ T cells stimulated with phorbol ester calcium ionophore: relation to kinetics of proliferation. Toxicol Appl Pharmacol. 1996a;138(2):324–334. [PubMed]
  • Ouyang YL, Li S, Pestka JJ. Effects of vomitoxin (deoxynivalenol) on transcription factor NF-kappa B/Rel binding activity in murine EL-4 thymoma and primary CD4+ T cells. Toxicol Appl Pharmacol. 1996b;140(2):328–336. [PubMed]
  • Parent-Massin D. Haematotoxicity of trichothecenes. Toxicol Lett. 2004;153(1):75–81. [PubMed]
  • Pestka J, Zhou HR. Hck- and PKR-dependent mitogen-activated protein kinase phosphorylation and AP-1, C/EBP and NF-kB activation precendes deoxynivalenol-induced TNF-2 and MIP-2 expression. The Toxicologist. 2003;72:121.
  • Pestka JJ. Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal immune response with systemic repercussions. Toxicol Lett. 2003;140-141:287–295. [PubMed]
  • Pestka JJ, Azcona Olivera JI, Plattner RD, Minervini F, Doko MB, Visconti A. Comparative assessment of fumonisin in grain-based foods by ELISA, GC-MS, and HPLC. J Food Prot. 1994a;57(2):169–172.
  • Pestka JJ, Dong W, Warner RL, Rasooly L, Bondy GS. Effect of dietary administration of the trichothecene vomitoxin (deoxynivalenol) on IgA and IgG secretion by Peyer’s patch and splenic lymphocytes. Food Chem Toxicol. 1990a;28(10):693–699. [PubMed]
  • Pestka JJ, Dong W, Warner RL, Rasooly L, Bondy GS, Brooks KH. Elevated membrane IgA+ and CD4+ (T helper) populations in murine Peyer’s patch and splenic lymphocytes during dietary administration of the trichothecene vomitoxin (deoxynivalenol) Food Chem Toxicol. 1990b;28(6):409–420. [PubMed]
  • Pestka JJ, Forsell JH. Inhibition of human lymphocyte transformation by the macrocyclic trichothecenes roridin A and verrucarin A. Toxicol Lett. 1988;41(3):215–222. [PubMed]
  • Pestka JJ, Lin WS, Miller ER. Emetic activity of the trichothecene 15-acetyldeoxynivalenol in swine. Food Chem Toxicol. 1987a;25(11):855–858. [PubMed]
  • Pestka JJ, Moorman MA, Warner RL. Dysregulation of IgA production and IgA nephropathy induced by the trichothecene vomitoxin. Food Chem Toxicol. 1989;27(6):361–368. [PubMed]
  • Pestka JJ, Moorman MA, Warner RL. Altered serum immunoglobulin response to model intestinal antigens during dietary exposure to vomitoxin (deoxynivalenol) Toxicol Lett. 1990c;50(1):75–84. [PubMed]
  • Pestka JJ, Smolinski AT. Deoxynivalenol: toxicology and potential effects on humans. J Toxicol Environ Health B Crit Rev. 2005;8(1):39–69. [PubMed]
  • Pestka JJ, Tai JH, Witt MF, Dixon DE, Forsell JH. Suppression of immune response in the B6C3F1 mouse after dietary exposure to the Fusarium mycotoxins deoxynivalenol (vomitoxin) and zearalenone. Food Chem Toxicol. 1987b;25(4):297–304. [PubMed]
  • Pestka JJ, Yan D, King LE. Flow cytometric analysis of the effects of in vitro exposure to vomitoxin (deoxynivalenol) on apoptosis in murine T, B and IgA+ cells. Food Chem Toxicol. 1994b;32(12):1125–1136. [PubMed]
  • Pestka JJ, Zhou HR. Interleukin-6-deficient mice refractory to IgA dysregulation but not anorexia induction by vomitoxin (deoxynivalenol) ingestion. Food Chem Toxicol. 2000;38(7):565–575. [PubMed]
  • Pestka JJ, Zhou HR, Moon Y, Chung YJ. Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox. Toxicol Lett. 2004;153(1):61–73. [PubMed]
  • Prelusky DB, Gerdes RG, Underhill KL, Rotter BA, Jui PY, Trenholm HL. Effects of low-level dietary deoxynivalenol on haematological and clinical parameters of the pig. Nat Toxins. 1994;2(3):97–104. [PubMed]
  • Prelusky DB, Trenholm HL. The efficacy of various classes of anti-emetics in preventing deoxynivalenol-induced vomiting in swine. Nat Toxins. 1993;1(5):296–302. [PubMed]
  • Rasooly L, Abouzied MM, Brooks KH, Pestka JJ. Polyspecific and autoreactive IgA secreted by hybridomas derived from Peyer’s patches of vomitoxin-fed mice: characterization and possible pathogenic role in IgA nephropathy. Food Chem Toxicol. 1994;32(4):337–348. [PubMed]
  • Rasooly L, Pestka JJ. Vomitoxin-induced dysregulation of serum IgA, IgM and IgG reactive with gut bacterial and self antigens. Food Chem Toxicol. 1992;30(6):499–504. [PubMed]
  • Rasooly L, Pestka JJ. Polyclonal autoreactive IgA increase and mesangial deposition during vomitoxin-induced IgA nephropahty in the BALB/c mouse. Food Chem Toxicol. 1994;32(4):329–336. [PubMed]
  • Robbana-Barnat S, Loridon-Rosa B, Cohen H, Lafarge-Frayssinet C, Neish GA, Frayssinet C. Protein synthesis inhibition and cardiac lesions associated with deoxynivalenol ingestion in mice. Food Addit Contam. 1987;4(1):49–56. [PubMed]
  • Rotter BA, Prelusky DB, Pestka JJ. Toxicology of deoxynivalenol (vomitoxin) J Toxicol Environ Health. 1996;48(1):1–34. [PubMed]
  • Rotter BA, Thompson BK, Lessard M, Trenholm HL, Tryphonas H. Influence of low-level exposure to Fusarium mycotoxins on selected immunological and hematological parameters in young swine. Fundam Appl Toxicol. 1994;23(1):117–124. [PubMed]
  • Schaeffer HJ, Weber MJ. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol. 1999;19(4):2435–2444. [PMC free article] [PubMed]
  • Schwartz GJ. Neural-immune gut-brain communication in the anorexia of disease. Nutrition. 2002;18(6):528–533. [PubMed]
  • Shifrin VI, Anderson P. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J Biol Chem. 1999;274(20):13985–13992. [PubMed]
  • Shinozuka J, Guanmin L, Uetsuka K, Nakayama H, Doi K. Process of the development of T-2 toxin-induced apoptosis in the lymphoid organs of mice. Exp Anim. 1997a;46(2):117–126. [PubMed]
  • Shinozuka J, Li G, Kiatipattanasakul W, Uetsuka K, Nakayama H, Doi K. T-2 toxin-induced apoptosis in lymphoid organs of mice. Exp Toxicol Pathol. 1997b;49(5):387–392. [PubMed]
  • Shinozuka J, Suzuki M, Noguchi N, Sugimoto T, Uetsuka K, Nakayama H, Doi K. T-2 toxin-induced apoptosis in hematopoietic tissues of mice. Toxicol Pathol. 1998;26(5):674–681. [PubMed]
  • Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000;69:145–182. [PubMed]
  • Sugiura Y, Watanabe Y, Tanaka T, Yamamoto S, Ueno Y. Occurrence of Gibberella zeae strains that produce both nivalenol and deoxynivalenol. Appl Environ Microbiol. 1990;56(10):3047–3051. [PMC free article] [PubMed]
  • Tanaka T, Yamamoto S, Hasegawa A, Aoki N, Besling JR, Sugiura Y, Ueno Y. A survey of the natural occurrence of Fusarium mycotoxins, deoxynivalenol, nivalenol and zearalenone, in cereals harvested in the Netherlands. Mycopathologia. 1990;110(1):19–22. [PubMed]
  • Tomar RS, Blakley BR, De Coteau WE. In vitro effects of T-2 toxin on the mitogen responsiveness and antibody-producing ability of human lymphocytes. Toxicol Lett. 1988;40(2):109–117. [PubMed]
  • Tomar RS, Blakley BR, DeCoteau WE. Immunological responsiveness of mouse spleen cells after in vivo or in vitro exposure to 3-acetyldeoxynivalenol. Food Chem Toxicol. 1987;25(5):393–398. [PubMed]
  • Tomar RS, Blakley BR, Schiefer HB, DeCoteau WE. In vitro effects of 3-acetyl-deoxynivalenol on the immune response of human peripheral blood lymphocytes. Int J Immunopharmacol. 1986;8(2):125–130. [PubMed]
  • Trenholm HL, Hamilton RM, Friend DW, Thompson BK, Hartin KE. Feeding trials with vomitoxin (deoxynivalenol)-contaminated wheat: effects on swine, poultry, and dairy cattle. J Am Vet Med Assoc. 1984;185(5):527–531. [PubMed]
  • Tsygankov AY. Non-receptor protein tyrosine kinases. Front Biosci. 2003;8:s595–s635. [PubMed]
  • Ueno Y. Toxicological features of T-2 toxin and related trichothecenes. Fundam Appl Toxicol. 1984;4(2 Pt 2):S124–S132. [PubMed]
  • Warner RL, Brooks K, Pestka JJ. In vitro effects of vomitoxin (Deoxynivalenol) on lymphocyte function: enhanced interleukin production and help for IgA secretion. Food Chem Toxicol. 1994;32(7):617–625. [PubMed]
  • Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev. 1999;79(1):143–180. [PubMed]
  • Williams BR. Signal integration via PKR. Sci STKE. 2001;89:RE2. [PubMed]
  • Wong SS, Zhou HR, Marin-Martinez ML, Brooks K, Pestka JJ. Modulation of IL-1beta, IL-6 and TNF-alpha secretion and mRNA expression by the trichothecene vomitoxin in the RAW 264.7 murine macrophage cell line. Food Chem Toxicol. 1998;36(5):409–419. [PubMed]
  • Wong SS, Zhou HR, Pestka JJ. Effects of vomitoxin (deoxynivalenol) on the binding of transcription factors AP-1, NF-kappaB, and NF-IL6 in raw 264.7 macrophage cells. J Toxicol Environ Health A. 2002;65(16):1161–1180. [PubMed]
  • Yan D, Zhou HR, Brooks KH, Pestka JJ. Potential role for IL-5 and IL-6 in enhanced IgA secretion by Peyer’s patch cells isolated from mice acutely exposed to vomitoxin. Toxicology. 1997;122(1–2):145–158. [PubMed]
  • Yan D, Zhou HR, Brooks KH, Pestka JJ. Role of macrophages in elevated IgA and IL-6 production by Peyer’s patch cultures following acute oral vomitoxin exposure. Toxicol Appl Pharmacol. 1998;148(2):261–273. [PubMed]
  • Yang G, Jarvis BB, Chung Y, Pestka JJ. Apoptosis induction by the satratoxins and other trichothecene mycotoxins: Relationship to ERK, p38 MAPK and SAPK/JNK Activation. Toxicol Appl Pharmacol. 2000;164(2):149–160. [PubMed]
  • Yeung MC, Liu J, Lau AS. An essential role for the interferon-inducible, double-stranded RNA- activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc Natl Acad Sci U S A. 1996;93(22):12451–12455. [PubMed]
  • Yoshizawa T, Takeda H, Ohim T. Structure of a novel metabolite from deoxynivalenol, a trichothecene mycotoxin, in animals. Agric Biol Chem. 1983;47:2133–2135.
  • Yoshizawa T. Trichothecenes--Chemical, Biological, and Toxicological Aspects. In: Ueno Y, editor. Dev Food Sci. Kodansha Ltd.; Tokyo, Japan: 1983. pp. 195–209.
  • Yoshizawa T, Morooka N. Trichothecenes in mold infested cereals in Japan. In: Rodricks JV, Hesseltine CW, Mehlman MA, editors. Mycotoxins in human and animal health. Pathotox Publishers, Inc; Park Forest South, Il: 1977. pp. 309–321.
  • Young LG, McGirr L, Valli VE, Lumsden JH, Lun A. Vomitoxin in corn fed to young pigs. J Anim Sci. 1983;57(3):655–664. [PubMed]
  • Zhou HR, Harkema JR, Yan D, Pestka JJ. Amplified proinflammatory cytokine expression and toxicity in mice coexposed to lipopolysaccharide and the trichothecene vomitoxin (deoxynivalenol) J Toxicol Environ Health. 1999;57(2):115–136. [PubMed]
  • Zhou HR, Islam Z, Pestka JJ. Rapid, sequential activation of mitogen-activated protein kinases and transcription factors precedes proinflammatory cytokine mRNA expression in spleens of mice exposed to the trichothecene vomitoxin. Toxicol Sci. 2003a;72(1):130–142. [PubMed]
  • Zhou HR, Islam Z, Pestka JJ. Induction of competing apoptotic and survival signaling pathways in the macrophage by the ribotoxic trichothecene deoxynivalenol. Toxicol Sci. 2005a;87(1):113–122. [PubMed]
  • Zhou HR, Jia Q, Pestka JJ. Ribotoxic stress response to the trichothecene deoxynivalenol in the macrophage involves the SRC family kinase Hck. Toxicol Sci. 2005b;85(2):916–926. [PubMed]
  • Zhou HR, Lau AS, Pestka JJ. Role of Double-Stranded RNA-Activated Protein Kinase R (PKR) in Deoxynivalenol-Induced Ribotoxic Stress Response. Toxicol Sci 2003b [PubMed]
  • Zhou HR, Pestka JJ. Deoxynivalenol-induced apoptosis mediated by p38 MAPK-dependent p53 gene induction in RAW 264.7 macrophages. The Toxicologist. 2003;72:330.
  • Zhou HR, Pestka JJ. Induction of competing apoptotic and survival signaling pathways in the macrophage by the ribotoxic trichothecene deoxynivalenol. Toxicol Sci 2005 [PubMed]
  • Zhou HR, Yan D, Pestka JJ. Differential cytokine mRNA expression in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): dose response and time course. Toxicol Appl Pharmacol. 1997;144(2):294–305. [PubMed]
  • Zhou HR, Yan D, Pestka JJ. Induction of cytokine gene expression in mice after repeated and subchronic oral exposure to vomitoxin (Deoxynivalenol): differential toxin-induced hyporesponsiveness and recovery. Toxicol Appl Pharmacol. 1998;151(2):347–358. [PubMed]